Correlation Between Aileron Therapeutics and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Aileron Therapeutics and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Salarius Pharmaceuticals.
Diversification Opportunities for Aileron Therapeutics and Salarius Pharmaceuticals
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aileron and Salarius is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aileron Therapeutics and Salarius Pharmaceuticals
Given the investment horizon of 90 days Aileron Therapeutics is expected to under-perform the Salarius Pharmaceuticals. In addition to that, Aileron Therapeutics is 1.13 times more volatile than Salarius Pharmaceuticals. It trades about -0.4 of its total potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about -0.08 per unit of volatility. If you would invest 167.00 in Salarius Pharmaceuticals on August 29, 2024 and sell it today you would lose (15.00) from holding Salarius Pharmaceuticals or give up 8.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aileron Therapeutics vs. Salarius Pharmaceuticals
Performance |
| Timeline |
| Aileron Therapeutics |
| Salarius Pharmaceuticals |
Aileron Therapeutics and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aileron Therapeutics and Salarius Pharmaceuticals
The main advantage of trading using opposite Aileron Therapeutics and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.| Aileron Therapeutics vs. Eliem Therapeutics | Aileron Therapeutics vs. Scpharmaceuticals | Aileron Therapeutics vs. Milestone Pharmaceuticals | Aileron Therapeutics vs. Seres Therapeutics |
| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |